Main therapeutic advances in IBD in 2008

A coimmunosuppression with azathioprine or methotrexate in addition to infliximab does not improve the therapeutic efficacy in Crohn's disease but increase the risks of infectious complications and neoplasia.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revue médicale suisse 2009-01, Vol.5 (187), p.185-190
Hauptverfasser:	Felley, C, Mottet, C, Hess, J, Maillard, M H, Delarive, J, Michetti, P
Format:	Artikel
Sprache:	fre
Schlagworte:	Chemoprevention Gastrointestinal Agents - therapeutic use Humans Inflammatory Bowel Diseases - therapy Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A coimmunosuppression with azathioprine or methotrexate in addition to infliximab does not improve the therapeutic efficacy in Crohn's disease but increase the risks of infectious complications and neoplasia.
ISSN:	1660-9379